Naloxone Market, By Strength (2.0 mg/ml, 1 mg/ml, 0.4 mg/ml, Others), By Route of Administration (Intranasal, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024

Code : CMI1804

Pages :199

Formats :

Excel and PDF

Industry : Pharmaceutical

Key Developments

In August 2023, Emergent BioSolutions Inc., a multinational specialty biopharmaceutical company, announced that NARCAN Naloxone HCl Nasal Spray 4 mg will be available statewide and online starting in September 2023. The manufacturer's suggested retail price for NARCAN Nasal Spray is USD 44.99 per carton, which equates to around USD 22.50 per dose.
On August 30, 2023, Walgreens, a pharmacy store chain in the U.S., announced that over-the-counter (OTC) NARCAN Nasal Spray will be available in Walgreens locations and online beginning September 5, with statewide availability on September 7, 2023.
In March 2023, Amneal Pharmaceuticals, Inc., a generics and specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for naloxone hydrochloride nasal spray, USP, 4mg, a generic version of Narcan used to treat a known or suspected opioid overdose emergency.
In December 2021, Sandoz, a global leader in generic and biosimilar medicines, today announced the US launch of its authorized generic version of Narcan (naloxone hydrochloride) Nasal Spray 4mg, which is used to treat opioid overdoses. It is readily available to consumers in the U.S. through retail pharmacies and institutions, including hospitals.